[HTML][HTML] Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review …
A Patwardhan, R Rennebohm, I Dvorchik… - Pediatric …, 2012 - Springer
Background We tested the hypothesis that the course and outcome of juvenile
dermatomyositis (JDM) in children seen at one center with the JDM disease onset at or …
dermatomyositis (JDM) in children seen at one center with the JDM disease onset at or …
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies
AM Huber, BM Feldman, RM Rennebohm… - Arthritis & …, 2004 - Wiley Online Library
Objective To examine the measurement characteristics of the Childhood Myositis
Assessment Scale (CMAS) in children with juvenile idiopathic inflammatory myopathy …
Assessment Scale (CMAS) in children with juvenile idiopathic inflammatory myopathy …
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials
LR Wedderburn, H Varsani, CKC Li… - Arthritis Care & …, 2007 - Wiley Online Library
Objective To devise and test a system with which to evaluate abnormalities on muscle
biopsy samples obtained from children diagnosed with juvenile dermatomyositis (DM) …
biopsy samples obtained from children diagnosed with juvenile dermatomyositis (DM) …
Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus
To examine the agreement and association between objectively measured and indirectly
assessed physical activity levels in patients with juvenile dermatomyositis (JDM) and …
assessed physical activity levels in patients with juvenile dermatomyositis (JDM) and …
Childhood arthritis and rheumatology research alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash
AM Huber, S Kim, AM Reed, R Carrasco… - The Journal of …, 2017 - jrheum.org
Objective. Juvenile dermatomyositis (JDM) is the most common form of idiopathic
inflammatory myopathy in children. While outcomes are generally thought to be good …
inflammatory myopathy in children. While outcomes are generally thought to be good …
Clinical analysis of 50 children with juvenile dermatomyositis
T Kishi, T Miyamae, R Hara, S Nakajima… - Modern …, 2013 - Taylor & Francis
Objective We performed a retrospective review of medical records to assess the clinical
characteristics of 50 Japanese children with juvenile dermatomyositis (JDM). Methods …
characteristics of 50 Japanese children with juvenile dermatomyositis (JDM). Methods …
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis
Objective To develop a provisional definition for the evaluation of response to therapy in
juvenile dermatomyositis (DM) based on the Paediatric Rheumatology International Trials …
juvenile dermatomyositis (DM) based on the Paediatric Rheumatology International Trials …
[PDF][PDF] Muscle biopsy findings in combination with myositis‐specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis
CT Deakin, SA Yasin, S Simou, KA Arnold… - Arthritis & …, 2016 - Wiley Online Library
Objective Juvenile dermatomyositis (DM) is a rare and severe autoimmune condition
characterized by rash and proximal muscle weakness. While some patients respond to …
characterized by rash and proximal muscle weakness. While some patients respond to …
[HTML][HTML] Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
R Campanilho-Marques, CT Deakin, S Simou… - Arthritis Research & …, 2020 - Springer
Background Anti-TNF treatment may be useful for the treatment of patients with refractory
juvenile dermatomyositis (JDM). The aim of this study was to describe the use of infliximab …
juvenile dermatomyositis (JDM). The aim of this study was to describe the use of infliximab …
Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis
SM Maillard, R Jones, C Owens, C Pilkington… - …, 2004 - academic.oup.com
Objective. The aim of the study was to examine the validity and reliability of a quantifiable
measure of inflammation using magnetic resonance imaging (MRI) in children with juvenile …
measure of inflammation using magnetic resonance imaging (MRI) in children with juvenile …